Samsung Bioepis Co., Ltd. today announced the launch of OPUVIZ 40 mg/mL solution in pre-ﬁlled syringe (PFS), a biosimilar referencing Eylea (aflibercept), across Europe, starting today

Opuviz (aflibercept-yszy) - AffaMed Therap, Biogen, Samsung, Harrow Health, Samil Pharma, Teva

Aug 10, 2026